301206 三元生物
已收盘 07-22 15:00:00
资讯
新帖
简况
三元生物:7月19日高管聂在建增持股份合计19.16万股
证券之星 · 07-19
三元生物:7月19日高管聂在建增持股份合计19.16万股
三元生物(301206.SZ)实控人增持19.16万股
智通财经 · 07-19
三元生物(301206.SZ)实控人增持19.16万股
三元生物(301206.SZ)实控人拟斥500万元到1000万元增持股份
智通财经 · 07-08
三元生物(301206.SZ)实控人拟斥500万元到1000万元增持股份
三元生物(301206.SZ)拟斥0.5亿元到1亿元回购股份
智通财经网 · 07-08
三元生物(301206.SZ)拟斥0.5亿元到1亿元回购股份
三元生物最新公告:控股股东、实际控制人、董事长聂在建拟增持500万元-1000万元
证券之星 · 07-08
三元生物最新公告:控股股东、实际控制人、董事长聂在建拟增持500万元-1000万元
三元生物最新公告:拟以5000万元-1亿元回购公司股份
证券之星 · 07-08
三元生物最新公告:拟以5000万元-1亿元回购公司股份
三元生物:为帮助客户更好地了解和使用公司产品,我们一直为所有客户提供样品
证券之星 · 06-14
三元生物:为帮助客户更好地了解和使用公司产品,我们一直为所有客户提供样品
三元生物:公司已经具备小规模生产能力,正在做市场推广,下一步将根据市场需求逐步扩大产能
证券之星 · 06-12
三元生物:公司已经具备小规模生产能力,正在做市场推广,下一步将根据市场需求逐步扩大产能
三元生物:项目审批因具体情况而异,有些项目的审批权限在市级以上部门
证券之星 · 06-08
三元生物:项目审批因具体情况而异,有些项目的审批权限在市级以上部门
三元生物:公司将部分募集资金用于现金管理,是为了在确保资金安全的前提下,提高资金使用效率
证券之星 · 06-07
三元生物:公司将部分募集资金用于现金管理,是为了在确保资金安全的前提下,提高资金使用效率
三元生物:公司高度重视募集资金的使用和管理,确保这些资金用于符合公司战略发展的项目,提高资金使用效率
证券之星 · 05-31
三元生物:公司高度重视募集资金的使用和管理,确保这些资金用于符合公司战略发展的项目,提高资金使用效率
三元生物:三元家纺是公司的关联公司,不纳入公司合并财务报表范围内
证券之星 · 05-27
三元生物:三元家纺是公司的关联公司,不纳入公司合并财务报表范围内
三元生物:公司将持续关注市场环境变化和相关风险,确保经营的稳定性和可持续发展
证券之星 · 05-27
三元生物:公司将持续关注市场环境变化和相关风险,确保经营的稳定性和可持续发展
三元生物(301206.SZ)拟10股派2.5元 于5月29日除权除息
智通财经 · 05-21
三元生物(301206.SZ)拟10股派2.5元 于5月29日除权除息
三元生物:公司深耕赤藓糖醇十余年,在以下方面取得了一定的优势
证券之星 · 05-21
三元生物:公司深耕赤藓糖醇十余年,在以下方面取得了一定的优势
三元生物:公司密切关注阿洛酮糖的市场动向,积极采取措施应对未来可能发生的竞争
证券之星 · 05-17
三元生物:公司密切关注阿洛酮糖的市场动向,积极采取措施应对未来可能发生的竞争
三元生物:公司2024年一季度的业绩增长,主要受益于赤藓糖醇销量增加
证券之星 · 05-15
三元生物:公司2024年一季度的业绩增长,主要受益于赤藓糖醇销量增加
三元生物(301206)5月14日主力资金净卖出1215.70万元
证券之星 · 05-15
三元生物(301206)5月14日主力资金净卖出1215.70万元
三元生物(301206)5月13日主力资金净卖出2054.33万元
证券之星 · 05-14
三元生物(301206)5月13日主力资金净卖出2054.33万元
三元生物:优质甜菊糖是一个全新的产品,公司已经具备小规模生产能力,正在做市场推广
证券之星 · 05-13
三元生物:优质甜菊糖是一个全新的产品,公司已经具备小规模生产能力,正在做市场推广
暂无数据
公司概况
公司名称:
山东三元生物科技股份有限公司
所属行业:
食品制造业
上市日期:
2022-02-10
主营业务:
山东三元生物科技股份有限公司主营业务是功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。公司的主要产品是赤藓糖醇及复配糖、阿洛酮糖。公司主要产品赤藓糖醇生产能力为13.5万吨,是目前全球规模最大的赤藓糖醇生产企业,在赤藓糖醇行业内具有良好的口碑和较强的品牌优势,公司生产的天绿原牌赤藓糖醇被评为“山东优质品牌”和“山东知名品牌”。
发行价格:
109.30
{"stockData":{"symbol":"301206","market":"SZ","secType":"STK","nameCN":"三元生物","latestPrice":24.15,"timestamp":1721631828000,"preClose":24.46,"halted":0,"volume":1098928,"delay":0,"floatShares":104000000,"shares":202000000,"eps":0.3723,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.31,"latestTime":"07-22 15:00:00","open":24.48,"high":24.88,"low":23.82,"amount":26669500,"amplitude":0.0433,"askPrice":24.16,"askSize":165,"bidPrice":24.15,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.3723,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":24.46,"symbolType":"stock","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":26.91,"lowLimit":22.01,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":202325700,"pbRate":1.08,"roa":"--","roe":"0.53%","epsLYR":0.29,"committee":-0.177843,"marketValue":4886000000,"floatMarketCap":2501000000,"peRate":64.867043,"changeRate":-0.0127,"turnoverRate":0.0106,"status":1},"requestUrl":"/m/hq/s/301206/tweets","defaultTab":"tweets","newsList":[{"id":"2452753484","title":"三元生物:7月19日高管聂在建增持股份合计19.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452753484","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452753484?lang=zh_cn&edition=full","pubTime":"2024-07-19 20:01","pubTimestamp":1721390470,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月19日市场公开信息、上市公司公告及交易所披露数据整理,三元生物最新董监高及相关人员股份变动情况:2024年7月19日公司董事长聂在建共增持公司股份19.16万股,占公司总股本为0.0947%。三元生物近半年内的董监高及核心技术人员增减持详情如下:三元生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出179.54万,融资余额减少;融券净流出1000.0,融券余额减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071900047480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2452242128","title":"三元生物(301206.SZ)实控人增持19.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452242128","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452242128?lang=zh_cn&edition=full","pubTime":"2024-07-19 19:17","pubTimestamp":1721387874,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三元生物(301206.SZ)公告,2024年7月19日,公司控股股东、实际控制人、董事长聂在建以集中竞价方式增持公司股份19.16万股,占公司当前总股本的0.09%。本次增持计划尚未实施完毕,增持主体将继续按照增持计划,在增持计划实施时间内增持公司股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2449040776","title":"三元生物(301206.SZ)实控人拟斥500万元到1000万元增持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2449040776","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449040776?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:34","pubTimestamp":1720438461,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三元生物(301206.SZ)发布公告,公司于近日收到控股股东、实际控制人、董事长聂在建出具的《关于增持公司股份计划的告知函》,拟增持金额不低于人民币500万元且不超过人民币1000万元。本次增持股份计划的实施期限自本公告披露之日起6个月内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2449776211","title":"三元生物(301206.SZ)拟斥0.5亿元到1亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2449776211","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449776211?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:32","pubTimestamp":1720438340,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三元生物(301206.SZ)发布公告,公司拟通过深圳证券交易所交易系统以集中竞价交易方式回购公司股份用于后期实施股权激励或员工持股计划。回购股份资金总额不低于人民币5000万元(含),且不超过人民币10000万元(含)。回购股份价格不超过35元/股(含)。回购股份实施期限自第四届董事会第二十三次会议审议通过回购股份方案之日起不超过12个月。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2449775316","title":"三元生物最新公告:控股股东、实际控制人、董事长聂在建拟增持500万元-1000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449775316","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449775316?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:00","pubTimestamp":1720436426,"startTime":"0","endTime":"0","summary":"三元生物公告,公司控股股东、实际控制人、董事长聂在建基于对公司未来持续稳定发展和长期投资价值的信心,拟使用自有资金计划自公告披露之日起6个月内,通过深圳证券交易所系统以集中竞价交易方式增持公司股份,拟增持金额不低于人民币500万元且不超过人民币1000万元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800025743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2449773537","title":"三元生物最新公告:拟以5000万元-1亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2449773537","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449773537?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:50","pubTimestamp":1720435828,"startTime":"0","endTime":"0","summary":"三元生物公告,拟以5000万元-1亿元回购公司股份,回购价格不超过35元/股,本次回购股份将用于后期实施股权激励或员工持股计划。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800025666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2443338647","title":"三元生物:为帮助客户更好地了解和使用公司产品,我们一直为所有客户提供样品","url":"https://stock-news.laohu8.com/highlight/detail?id=2443338647","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443338647?lang=zh_cn&edition=full","pubTime":"2024-06-14 18:03","pubTimestamp":1718359396,"startTime":"0","endTime":"0","summary":"为帮助客户更好地了解和使用公司产品,我们一直为所有客户提供样品。请问三元生物小包装产品一直没有进展和推广是否也有这个原因?未来,随着阿洛酮糖在更多国家和地区获准上市,公司将通过多元化的产品组合来满足不同市场的需求,减少对单一产品的依赖,尽量减弱潜在市场波动带来的影响。主要是因为2024年一季度主营产品销量同比增加,使得固定资产折旧等产品单位成本同比下降所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061400036439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2442350085","title":"三元生物:公司已经具备小规模生产能力,正在做市场推广,下一步将根据市场需求逐步扩大产能","url":"https://stock-news.laohu8.com/highlight/detail?id=2442350085","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442350085?lang=zh_cn&edition=full","pubTime":"2024-06-12 18:03","pubTimestamp":1718186591,"startTime":"0","endTime":"0","summary":"公司已经具备小规模生产能力,正在做市场推广,下一步将根据市场需求逐步扩大产能。公司将根据市场需求,灵活调整产能,持续提升市场竞争力。公司在并购及市场扩张方面会进行全面的战略评估和审慎考虑,目前暂无并购计划。公司已经做好了生产小包装糖的各项准备,并将在时机成熟时启动销售。三元生物董秘:投资者您好,截至6月7日公司在册股东共15847户,谢谢关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061200034884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2441027985","title":"三元生物:项目审批因具体情况而异,有些项目的审批权限在市级以上部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2441027985","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441027985?lang=zh_cn&edition=full","pubTime":"2024-06-08 17:00","pubTimestamp":1717837231,"startTime":"0","endTime":"0","summary":"证券之星消息,三元生物06月08日在投资者关系平台上答复投资者关心的问题。项目审批因具体情况而异,有些项目的审批权限在市级以上部门。项目审批过程复杂,涉及政策变化、审批程序及材料准备等多方面因素。投资者:请问三元生物现在净利润超过1千万的产品有哪些?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060800015110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2441505312","title":"三元生物:公司将部分募集资金用于现金管理,是为了在确保资金安全的前提下,提高资金使用效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2441505312","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441505312?lang=zh_cn&edition=full","pubTime":"2024-06-07 18:03","pubTimestamp":1717754595,"startTime":"0","endTime":"0","summary":"公司将部分募集资金用于现金管理,是为了在确保资金安全的前提下,提高资金使用效率。本次欧盟对中国赤藓糖醇的反倾销调查目前处于调查阶段,尚未有裁定结果。依据调查程序,预计初步裁定结果和最终裁定结果将分别于 2024 年 6 月 21 日和2024 年 12 月 20 日左右公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060700036998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2439965223","title":"三元生物:公司高度重视募集资金的使用和管理,确保这些资金用于符合公司战略发展的项目,提高资金使用效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2439965223","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439965223?lang=zh_cn&edition=full","pubTime":"2024-05-31 18:03","pubTimestamp":1717149805,"startTime":"0","endTime":"0","summary":"公司科研人员已经签署保密协议。除了三元生物,国内还有许多公司共同致力于赤藓糖醇的生产和推广,包括跨国公司、知名上市公司和民营企业,以及近年来跨界进入该领域的新兴企业。公司高度重视募集资金的使用和管理,确保这些资金用于符合公司战略发展的项目,提高资金使用效率。超募资金的使用将严格按照相关规定进行,并及时披露相关信息。据公司了解,目前没有权威机构报道阿洛酮糖会引起肥胖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053100036298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2438885583","title":"三元生物:三元家纺是公司的关联公司,不纳入公司合并财务报表范围内","url":"https://stock-news.laohu8.com/highlight/detail?id=2438885583","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438885583?lang=zh_cn&edition=full","pubTime":"2024-05-27 19:01","pubTimestamp":1716807699,"startTime":"0","endTime":"0","summary":"证券之星消息,三元生物(301206)05月27日在投资者关系平台上答复投资者关心的问题。投资者:请问三元生物的三元家纺属于子公司合并财务报表了吗?三元生物董秘:投资者您好,三元家纺是公司的关联公司,不纳入公司合并财务报表范围内,谢谢关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700022722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2438805085","title":"三元生物:公司将持续关注市场环境变化和相关风险,确保经营的稳定性和可持续发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2438805085","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438805085?lang=zh_cn&edition=full","pubTime":"2024-05-27 17:03","pubTimestamp":1716800600,"startTime":"0","endTime":"0","summary":"公司将持续关注市场环境变化和相关风险,确保经营的稳定性和可持续发展。公司将严格按照会计准则和相关规定,对募投项目进行管理。公司将综合考虑市场环境和公司财务状况、上市承诺、发展战略和股东利益,审慎评估资金用途,适时开展股份回购,确保募集资金的有效使用和公司可持续发展。公司采取多种措施积极应对,保持了客户和经销商数量的相对稳定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700020165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2437492069","title":"三元生物(301206.SZ)拟10股派2.5元 于5月29日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2437492069","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437492069?lang=zh_cn&edition=full","pubTime":"2024-05-21 18:08","pubTimestamp":1716286131,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三元生物(301206.SZ)公告,公司2023年年度权益分派拟:向全体股东每10股派2.5元(含税);除权除息日为:2024年5月29日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1123956.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2437997514","title":"三元生物:公司深耕赤藓糖醇十余年,在以下方面取得了一定的优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2437997514","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437997514?lang=zh_cn&edition=full","pubTime":"2024-05-21 17:05","pubTimestamp":1716282315,"startTime":"0","endTime":"0","summary":"公司深耕赤藓糖醇十余年,在以下方面取得了一定的优势。在近两年的赤藓糖醇价格战中,公司产品销量受到了较大影响。由于缺乏足够的数据来精确计算公司赤藓糖醇的市场份额,建议您关注行业研究机构发布的相关报告,以获取准确的市场份额信息。2022年下半年以来,赤藓糖醇行业产能严重过剩,引发激烈的价格战,对公司销售造成了较大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052100028724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2436035991","title":"三元生物:公司密切关注阿洛酮糖的市场动向,积极采取措施应对未来可能发生的竞争","url":"https://stock-news.laohu8.com/highlight/detail?id=2436035991","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436035991?lang=zh_cn&edition=full","pubTime":"2024-05-17 18:03","pubTimestamp":1715940195,"startTime":"0","endTime":"0","summary":"公司重点关注合成生物学在功能糖领域的应用,希望能够借助最前沿的生物科技获得一定的市场竞争优势。公司密切关注阿洛酮糖的市场动向,积极采取措施应对未来可能发生的竞争。目前,阿洛酮糖及其复配产品在北美、韩国市场比较活跃,初步呈现出供不应求的迹象,公司正在快速扩产,抢占市场。公司在并购及市场扩张方面会进行全面的战略评估和审慎考虑,目前暂无并购计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051700035836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2435259635","title":"三元生物:公司2024年一季度的业绩增长,主要受益于赤藓糖醇销量增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2435259635","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435259635?lang=zh_cn&edition=full","pubTime":"2024-05-15 19:02","pubTimestamp":1715770920,"startTime":"0","endTime":"0","summary":"投资者:三元生物2024年一季度利润增加226.72%,贡献利润最高的是什么?公司2024年一季度的业绩增长,主要受益于赤藓糖醇销量增加。2022年下半年以来,赤藓糖醇激烈的价格战给公司带来一定挑战,但公司采取多种措施积极应对,一直保持持续生产。2024年一季度销量的增长使产能利用率明显提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500031858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2435579348","title":"三元生物(301206)5月14日主力资金净卖出1215.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435579348","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435579348?lang=zh_cn&edition=full","pubTime":"2024-05-15 09:20","pubTimestamp":1715736027,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月14日收盘,三元生物报收于29.88元,下跌1.97%,换手率6.08%,成交量6.29万手,成交额1.95亿元。近5日资金流向一览见下表:三元生物融资融券信息显示,融资方面,当日融资买入2300.88万元,融资偿还1193.02万元,融资净买入1107.86万元。三元生物主营业务:主要从事功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500015427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2435941533","title":"三元生物(301206)5月13日主力资金净卖出2054.33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435941533","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435941533?lang=zh_cn&edition=full","pubTime":"2024-05-14 09:19","pubTimestamp":1715649578,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月13日收盘,三元生物报收于30.48元,下跌6.22%,换手率6.52%,成交量6.75万手,成交额2.08亿元。近5日资金流向一览见下表:三元生物融资融券信息显示,融资方面,当日融资买入2526.39万元,融资偿还1419.42万元,融资净买入1106.97万元。三元生物主营业务:主要从事功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400008728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2435340478","title":"三元生物:优质甜菊糖是一个全新的产品,公司已经具备小规模生产能力,正在做市场推广","url":"https://stock-news.laohu8.com/highlight/detail?id=2435340478","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435340478?lang=zh_cn&edition=full","pubTime":"2024-05-13 18:03","pubTimestamp":1715594601,"startTime":"0","endTime":"0","summary":"优质甜菊糖是一个全新的产品,公司已经具备小规模生产能力,正在做市场推广。山东沛学生物工程有限公司定位于口服透明质酸在功能性食品领域的产品开发、生产和销售,侧重于科技成果产业化的市场端应用,服务于广大消费者。食品级透明质酸是公司的储备品种之一,目前已完成中试,下一步将根据市场需求和推广情况研究制定量产计划。公司已经做好了生产小包装糖的各项准备,并将在时机成熟时积极寻求进入商超的市场机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300019992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-02-10","address":"山东省滨州市滨城区滨北张富路89号","stockEarnings":[{"period":"1week","weight":-0.0192},{"period":"1month","weight":-0.0427},{"period":"3month","weight":-0.0088},{"period":"6month","weight":-0.0811},{"period":"1year","weight":-0.1919},{"period":"ytd","weight":-0.1454}],"companyName":"山东三元生物科技股份有限公司","boardCode":"AI0014","perCapita":"6772股","boardName":"食品制造业","registeredCapital":"20232万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":" 山东三元生物科技股份有限公司主营业务是功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。公司的主要产品是赤藓糖醇及复配糖、阿洛酮糖。公司主要产品赤藓糖醇生产能力为13.5万吨,是目前全球规模最大的赤藓糖醇生产企业,在赤藓糖醇行业内具有良好的口碑和较强的品牌优势,公司生产的天绿原牌赤藓糖醇被评为“山东优质品牌”和“山东知名品牌”。","serverTime":1721663429904,"listedPrice":109.3,"stockholders":"15289人(较上一季度减少2.11%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三元生物,301206,三元生物股票,三元生物股票老虎,三元生物股票老虎国际,三元生物行情,三元生物股票行情,三元生物股价,三元生物股市,三元生物股票价格,三元生物股票交易,三元生物股票购买,三元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}